Suchergebnisse - "Kokowski, Konrad"

PubPharm (18)

1

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

enthalten in: JTO clinical and research reports | 2024

von Griesinger, F. | Sebastian, M. | Brueckl, W. | +117

2

SAPPHIRE : phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Borghaei, H. | de Marinis, F. | Dumoulin, D. | +118

3

Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice : A subset analysis of the non-interventional GIDEON study

enthalten in: Journal of geriatric oncology | 2023

von Brueckl, W. | Reck, M. | Schäfer, H. | +9

4

KRAS G12C-mutated advanced non-small cell lung cancer : A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Sebastian, M. | Eberhardt, W. | Hoffknecht, P. | +22

5

Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

enthalten in: Therapeutic advances in medical oncology | 2021

von Brückl, W. | Reck, M. | Griesinger, F. | +11

6

Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

sonderdruck aus: Therapeutic advances in medical oncology | 2021

von Brückl, W. | Reck, M. | Griesinger, F. | +11

7

Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy : A Randomized Phase II Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Multhoff, G. | Seier, S. | Stangl, S. | +22

8

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2020

von Wolf, J. | Seto, T. | Han, J. | +127

9

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control : a case study

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

10

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

enthalten in: Strahlentherapie und Onkologie | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3